Princeton, New Jersey Tuesday, July 22, 2025, 12:00 Hrs [IST] ...

Our warm weather season is short, and it's important to enjoy the outdoors. The point isn't to be sun-scared — just stay ...

British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence ...

This was the stock's second consecutive day of losses.

A new genetic test, based on data from more than five million people, can identify people at risk of severe obesity. The test can be performed on children before their genetic risk starts to shape ...

The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for deucravacitinib for the treatment of adults with active psoriatic arthritis (PsA).

The US Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for Sotyktu ...

Icotrokinra is a first-in-class targeted oral peptide that blocks interleukin (IL) 23 and its receptor, which plays a key role in the inflammatory response in plaque psoriasis.

We recently published 8 Stocks That Jim Cramer Recently Talked About. Bristol-Myers Squibb Company (NYSE:BMY) is one of the ...

Domino’s reported better-than-expected second-quarter US sales, with new menu items ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Guggenheim ...

The glory days were already long past for late-night TV when CBS announced last week that it was pulling "The Late Show" ...